Literature DB >> 24255784

Research status and funding trends of lung cancer biomarkers.

Cui Li1, Wei Hong.   

Abstract

Lung cancer is one of malignant tumors with the highest morbidity and mortality in the world. At present, research of early diagnosis, treatment, prognosis, and metastasis associated biomarkers is most active. This article reviewed the research status of lung cancer biomarkers and analyzed the funding situation in the field of lung cancer markers in recent 10 years in China and abroad, to provide a reference for the future basic and clinical translational research of lung cancer biomarkers.

Entities:  

Keywords:  Lung cancer; molecular biomarker; research grants

Year:  2013        PMID： 24255784      PMCID： PMC3815715          DOI： 10.3978/j.issn.2072-1439.2013.10.10

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


  58 in total

1.  Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer.

Authors:  Ruiyun Li; Nevins W Todd; Qi Qiu; Tao Fan; Richard Y Zhao; William H Rodgers; Hong-Bin Fang; Ruth L Katz; Sanford A Stass; Feng Jiang
Journal:  Clin Cancer Res       Date:  2007-01-15       Impact factor: 12.531

2.  Proteomic patterns of preinvasive bronchial lesions.

Authors:  S M Jamshedur Rahman; Yu Shyr; Pinar B Yildiz; Adriana L Gonzalez; Huiming Li; Xueqiong Zhang; Pierre Chaurand; Kiyoshi Yanagisawa; Bonnie S Slovis; Robert F Miller; Mathew Ninan; York E Miller; Wilbur A Franklin; Richard M Caprioli; David P Carbone; Pierre P Massion
Journal:  Am J Respir Crit Care Med       Date:  2005-09-22       Impact factor: 21.405

3.  Gefitinib (IRESSA) in patients of Asian origin with refractory advanced non-small cell lung cancer: subset analysis from the ISEL study.

Authors:  Alex Chang; Purvish Parikh; Sumitra Thongprasert; Eng Huat Tan; Reury-Perng Perng; Domingo Ganzon; Chih-Hsin Yang; Chao-Jung Tsao; Claire Watkins; Nick Botwood; Nick Thatcher
Journal:  J Thorac Oncol       Date:  2006-10       Impact factor: 15.609

4.  [An analysis of lung cancer mortality in China, 2004 - 2005].

Authors:  Wan-qing Chen; Si-wei Zhang; Xiao-nong Zou; Ping Zhao
Journal:  Zhonghua Yu Fang Yi Xue Za Zhi       Date:  2010-05

5.  Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.

Authors:  Zhibin Hu; Xi Chen; Yang Zhao; Tian Tian; Guangfu Jin; Yongqian Shu; Yijiang Chen; Lin Xu; Ke Zen; Chenyu Zhang; Hongbing Shen
Journal:  J Clin Oncol       Date:  2010-03-01       Impact factor: 44.544

Review 6.  Potential molecular approaches for the early diagnosis of lung cancer (review).

Authors:  Chul Ho Oak; Donald Wilson; Hu Jang Lee; Ho-Ju Lim; Eun-Kee Park
Journal:  Mol Med Rep       Date:  2012-08-21       Impact factor: 2.952

Review 7.  MicroRNAs in the pathogenesis of Lung Cancer.

Authors:  Xin Wu; Melissa G Piper-Hunter; Melissa Crawford; Gerard J Nuovo; Clay B Marsh; Gregory A Otterson; Serge P Nana-Sinkam
Journal:  J Thorac Oncol       Date:  2009-08       Impact factor: 15.609

8.  Lung cancer susceptibility and genetic polymorphism of DNA repair gene XRCC4 in Taiwan.

Authors:  Nan-Yung Hsu; Hwei-Chung Wang; Chung-Hsing Wang; Chia-Lin Chang; Chang-Fang Chiu; Hong-Zin Lee; Chia-Wen Tsai; Da-Tian Bau
Journal:  Cancer Biomark       Date:  2009       Impact factor: 4.388

9.  A gene expression signature predicts survival of patients with stage I non-small cell lung cancer.

Authors:  Yan Lu; William Lemon; Peng-Yuan Liu; Yijun Yi; Carl Morrison; Ping Yang; Zhifu Sun; Janos Szoke; William L Gerald; Mark Watson; Ramaswamy Govindan; Ming You
Journal:  PLoS Med       Date:  2006-12       Impact factor: 11.069

10.  Do genetic factors protect for early onset lung cancer? A case control study before the age of 50 years.

Authors:  Albert Rosenberger; Thomas Illig; Katrin Korb; Norman Klopp; Vera Zietemann; Gabi Wölke; Eckart Meese; Gerhard Sybrecht; Florian Kronenberg; Matthias Cebulla; Maria Degen; Peter Drings; Andreas Gröschel; Nikolaus Konietzko; Karsten Grosse Kreymborg; Karl Häussinger; Gerd Höffken; Bettina Jilge; You-Dschun Ko; Harald Morr; Christine Schmidt; E-Wilhelm Schmidt; Dagmar Täuscher; Heike Bickeböller; H-Erich Wichmann
Journal:  BMC Cancer       Date:  2008-02-25       Impact factor: 4.430
View more
  10 in total

1.  Reduced E-Cadherin expression is a prognostic biomarker of non-small cell lung cancer: a meta-analysis based on 2395 subjects.

Authors:  Bo Yan; Wei Zhang; Li-Yan Jiang; Wen-Xin Qin; Xin Wang
Journal:  Int J Clin Exp Med       Date:  2014-11-15

2.  Effect of edaravone on serum SP-A and arterial blood gas in patients with lobectomy.

Authors:  Li Song; Feng Xiong; Xue-Juan Zhang; Wei-Yi Liu; Yang Zhao; Wei Feng
Journal:  Int J Clin Exp Med       Date:  2015-06-15

3.  Diagnostic value of serum glutathione peroxidase 3 levels in patients with lung cancer.

Authors:  In-Jae Oh; Hye-Eun Kim; Sang-Yun Song; Kook-Joo Na; Kyu-Sik Kim; Young-Chul Kim; Seung-Won Lee
Journal:  Thorac Cancer       Date:  2014-08-25       Impact factor: 3.500

4.  Epigenetic Profiling of H3K4Me3 Reveals Herbal Medicine Jinfukang-Induced Epigenetic Alteration Is Involved in Anti-Lung Cancer Activity.

Authors:  Jun Lu; Xiaoli Zhang; Tingting Shen; Chao Ma; Jun Wu; Hualei Kong; Jing Tian; Zhifeng Shao; Xiaodong Zhao; Ling Xu
Journal:  Evid Based Complement Alternat Med       Date:  2016-03-20       Impact factor: 2.629

5.  Transcriptome Profiling Reveals the Antitumor Mechanism of Polysaccharide from Marine Algae Gracilariopsis lemaneiformis.

Authors:  Yani Kang; Hua Li; Jun Wu; Xiaoting Xu; Xue Sun; Xiaodong Zhao; Nianjun Xu
Journal:  PLoS One       Date:  2016-06-29       Impact factor: 3.240

6.  MicroRNA-107 inhibits tumor growth and metastasis by targeting the BDNF-mediated PI3K/AKT pathway in human non-small lung cancer.

Authors:  Huan Xia; Yang Li; Xiaohong Lv
Journal:  Int J Oncol       Date:  2016-07-25       Impact factor: 5.650

7.  Jinfukang induces cellular apoptosis through activation of Fas and DR4 in A549 cells.

Authors:  Jun Lu; Jian Chen; Yani Kang; Jun Wu; Hui Shi; Yanli Fu; Lijing Jiao; Changsheng Dong; Xiaowei Li; Yu Jin; Wei Zhao; Ling Xu; Xiaodong Zhao
Journal:  Oncol Lett       Date:  2018-07-16       Impact factor: 2.967

8.  Biosynthesis, characterization, and anticancer effect of plant-mediated silver nanoparticles using Coptis chinensis.

Authors:  Junwen Pei; Binfan Fu; Lifeng Jiang; Taizhen Sun
Journal:  Int J Nanomedicine       Date:  2019-03-15

9.  Could Jinfukang alleviate the chemotherapy-related adverse effects in non-small cell lung cancer patients?: A protocol for a double-blind, randomized controlled trial.

Authors:  Xing Zheng; Wenmin Wang; Gefei Wang; Shenghua Liu
Journal:  Medicine (Baltimore)       Date:  2021-07-16       Impact factor: 1.817

10.  microRNA-605 promotes cell proliferation, migration and invasion in non-small cell lung cancer by directly targeting LATS2.

Authors:  Ying Ye; Juhua Zhuang; Guoyu Wang; Saifei He; Jing Ni; Wei Xia; Jiening Wang
Journal:  Exp Ther Med       Date:  2017-06-01       Impact factor: 2.751
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.